000 01652 a2200457 4500
005 20250517194320.0
264 0 _c20181211
008 201812s 0 0 eng d
022 _a1095-9572
024 7 _a10.1016/j.neuroimage.2018.01.013
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVallianatou, Theodosia
245 0 0 _aA mass spectrometry imaging approach for investigating how drug-drug interactions influence drug blood-brain barrier permeability.
_h[electronic resource]
260 _bNeuroImage
_c05 2018
300 _a808-816 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aATP Binding Cassette Transporter, Subfamily B, Member 1
_xmetabolism
650 0 4 _aAnimals
650 0 4 _aBlood-Brain Barrier
_xdrug effects
650 0 4 _aCapillary Permeability
_xdrug effects
650 0 4 _aDrug Interactions
650 0 4 _aLoperamide
_xpharmacokinetics
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aMice, Inbred C57BL
650 0 4 _aPropranolol
_xpharmacokinetics
650 0 4 _aSpectrometry, Mass, Electrospray Ionization
_xmethods
650 0 4 _aTissue Distribution
700 1 _aStrittmatter, Nicole
700 1 _aNilsson, Anna
700 1 _aShariatgorji, Mohammadreza
700 1 _aHamm, Gregory
700 1 _aPereira, Marcela
700 1 _aKällback, Patrik
700 1 _aSvenningsson, Per
700 1 _aKarlgren, Maria
700 1 _aGoodwin, Richard J A
700 1 _aAndrén, Per E
773 0 _tNeuroImage
_gvol. 172
_gp. 808-816
856 4 0 _uhttps://doi.org/10.1016/j.neuroimage.2018.01.013
_zAvailable from publisher's website
999 _c27976008
_d27976008